Differential high density lipoprotein proteomic profile in heterozygous familial hypercholesterolemia

被引:0
|
作者
Cubedo, J. [1 ]
Padro, T.
Alonso, R. [2 ]
Mata, P. [2 ]
Badimon, L. [1 ]
机构
[1] UAB, Hosp St Pau, IIB St Pau, Barcelona Cardiovasc Res Ctr,CSIC ICCC,CiberOBN, Barcelona, Spain
[2] Fdn Jimenez Diaz, E-28040 Madrid, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S121 / S122
页数:2
相关论文
共 50 条
  • [41] Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia
    Martinez, Lilton R. C.
    Santos, Raul D.
    Miname, Marcio H.
    Deus, Debora F.
    Lima, Emerson S.
    Maranhao, Raul C.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (08): : 1061 - 1064
  • [42] Effect of fluvastatin or bezafibrate on the distribution of high density lipoprotein subpopulations in patients with familial hypercholesterolemia
    Hailer, S
    Pogarell, O
    Keller, C
    Wolfram, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1996, 46 (09): : 879 - 883
  • [43] Is High-Density Lipoprotein Functionality Useful as a Residual Risk Marker for Familial Hypercholesterolemia?
    Ogura, Masatsune
    CIRCULATION JOURNAL, 2023, 87 (06) : 813 - 814
  • [44] CIRCULATING SOLUBLE LOW DENSITY LIPOPROTEIN RECEPTOR LEVELS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA SUBJECTS BEFORE AND AFTER STATIN THERAPY
    Ooi, Teik C.
    Gaudet, Daniel
    Brisson, Diane
    Tepliakova, Lioudmila
    Figeys, Daniel
    Mayne, Janice
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 60 - 61
  • [45] Variety of low-density-lipoprotein-receptor gene mutations and expression of coronary artery disease in heterozygous familial hypercholesterolemia
    Higashikata, T
    Kajinami, K
    Yagi, K
    Inazu, A
    Matsushita, H
    Nohara, A
    Koizumi, J
    Mabuchi, H
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 69 - 69
  • [46] REDUCTION IN PLASMA LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND URINARY MEVALONIC ACID BY LOVASTATIN IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    PAPPU, AS
    ILLINGWORTH, DR
    BACON, S
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (06): : 542 - 549
  • [47] Compound heterozygous familial hypercholesterolemia in a Chinese boy with a de novo and transmitted low-density lipoprotein receptor mutation
    Ma, Yizhe
    Gong, Yingyun
    Garg, Abhimanyu
    Zhou, Hongwen
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (01) : 230 - 235
  • [48] EFFECTS OF LOVASTATIN AND GEMFIBROZIL ON HIGH-DENSITY-LIPOPROTEIN SUBFRACTION DENSITY AND COMPOSITION IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    TILLYKIESI, M
    TIKKANEN, MJ
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1992, 120 (01): : 103 - 110
  • [49] Effects of colestimide in addition to atorvastatin on low-density lipoprotein (LDL) cholesterol in patients with heterozygous familial hypercholesterolemia (FH)
    Kawashiri, M
    Higashikata, T
    Tsuchida, M
    Takata, M
    Katsuda, S
    Miwa, K
    Inazu, A
    Mabuchi, H
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 172 - 172
  • [50] Flow cytometric measurement of low density lipoprotein receptor activity validated by DNA analysis in diagnosing heterozygous familial hypercholesterolemia
    Urdal, P
    Leren, TP
    Tonstad, S
    Lund, PK
    Ose, L
    CYTOMETRY, 1997, 30 (05): : 264 - 268